Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Donald Beasley

Otolaryngology Boise, ID Medical Doctor

NPI 1770573750 CMS profile 79885

8854 W Emerald St Ste 150, Ste 150, Boise, ID 83704

Open in the dashboard

General payments

$6,740

68 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Donald Beasley of Boise, ID is reported in the CMS Open Payments database as having received $6,740 across 68 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $119 3
2024 General $116 2
2023 General $396 5
2022 General $2,406 22
2021 General $2,422 30
2020 General $1,281 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Donald Beasley
  • Otolaryngology median
  • Middle half of Otolaryngology
  • National median

In program year 2025, general payments to Donald Beasley were reported at $119. Among 6,588 Otolaryngology profiles paid that year, the median was $317 and the middle half received between $125 and $815.

Show as a table
Year Donald Beasley Otolaryngology median Middle half National median
2019 $0 $194 $82–$512 $163
2020 $1,281 $118 $42–$280 $114
2021 $2,422 $167 $63–$444 $132
2022 $2,406 $216 $84–$545 $149
2023 $396 $235 $93–$588 $160
2024 $116 $280 $111–$699 $164
2025 $119 $317 $125–$815 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Stryker Corporation $3,296 25 payments
  2. Medtronic, Inc. $2,740 30 payments
  3. Acclarent, Inc $380 7 payments
  4. Merz North America, Inc. $260 3 payments
  5. Integra LifeSciences Corporation $28 1 payment
  6. Pacira Pharmaceuticals Incorporated $18 1 payment
  7. Intersect ENT, Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $4,039 57 payments
  2. Travel and Lodging $2,700 11 payments
Products named General payments · program years 2020–2025
  1. NUVENT $2,124 19 payments
  2. XPRESS ENT DILATION SYSTEM $1,151 16 payments
  3. ENTELLUS - XPRESS ENT DILATION SYSTEM $1,098 3 payments
  4. SCOPIS ENT $866 3 payments
  5. Relieva Spinplus $279 5 payments
  6. ENTELLUS MEDICAL REINFORCED ANESTHESIA NEEDLE $271 3 payments
  7. Xeomin $245 1 payment
  8. PROPEL $198 4 payments
  9. SHAVER SYSTEM $175 2 payments
  10. XEROGEL NASAL/EPISTAXIS 2 PACK $175 2 payments
  11. Other $1,038 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$202,046

Medicare's payments for the services billed

Medicare patients

136

Average age 73

Services billed

571

64 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 58%
Arthritis 55%
Ischemic heart disease 21%
Diabetes 17%
Depression 17%
Osteoporosis 14%
Cancer 13%
Heart failure 10%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

68 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Otolaryngology in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record